SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
132.689 0.3 (0.23%)

NAV as on 17 Jan, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Dec 30, 16)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 129.16 15.00
Strides Shasun Pharmaceuticals 81.80 9.50
Cipla Pharmaceuticals 77.84 9.04
Aurobindo Pharm Pharmaceuticals 71.56 8.31
Lupin Pharmaceuticals 50.89 5.91
Divis Labs Pharmaceuticals 50.29 5.84
Glenmark Pharmaceuticals 45.64 5.30
Laurus Labs Pharmaceuticals 35.91 4.17
Thyrocare Techn Services 35.56 4.13
Natco Pharma Pharmaceuticals 34.70 4.03
Sector Allocation (Dec 30, 16)
  Sector   % 1-Year
High Low

Pharmaceuticals

89.82 95.88 91.18

Services

6.51 6.06 2.80
Asset Allocation (%) (Dec 30, 16)
Class
%

Equity

96.33

Others / Unlisted

1.07

Debt

0.00

Mutual Funds

N.A

Money Market

2.67

Cash / Call

-0.07

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

47.76

Top 10

71.23
Sectors
%

Top 3

96.33
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.